EN
HI
Concord Biotech Chart
Concord Biotech Share Key Metrics
Volume
3.36 L
Market Cap
10997.26 CR
LTQ@LTP
50@1051.20
ATP
1070.97
Var Margin
20.52 %
Circuit Range
879.7-1319.5
Delivery %
58.83 %
Value
35.98 CR
ASM/GSM
No
Market Lot
1
Summary
Concord Biotech share price is ₹1051.2 as of 29 May, 2026. The stock Concord Biotech intraday movement has stayed between ₹1040.30 and ₹1123.60, while on a 52-week basis,Concord Biotech price 52 week high is ₹2150.40 & its 52 week low is ₹987.00.
In terms of trading activity, Concord Biotech has recorded a volume of 335959 shares, The Concord Biotech has a market cap of ₹104616204 CR. The stock’s Average Traded Price (ATP) stands at ₹1070.97, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹1051.20.
Concord Biotech operates within a circuit range of ₹879.70 – ₹1319.50, with a Value of ₹35.98 CR. The Delivery Percentage for the day is 58.83%. Additionally, Concord Biotech currently falls under the No framework, and trades with a market lot size of 1.
Concord Biotech Fundamentals
View MoreP/E Ratio
36.8
P/B Ratio
6.08
Div. Yield
0.97
Sector P/E
55.51
Sector P/B
3.01
Sec. Div. Yield
0.55
Concord Biotech Resistance and Support
Pivot 1113.77
Resistance
First Resistance
1131.34
Second Resistance
1163.07
Third Resistance
1180.64
Support
First Support
1082.04
Second Support
1064.47
Third Support
1032.74
Concord Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Concord Biotech News
Concord Biotech Ltd - 543960 - Corporate Action-Board approves Dividend
Concord Biotech's board recommended a final dividend of ₹7.55 per equity share for FY26. The record date for the dividend payout is July 24, 2026, pending shareholder approval.
May 29 2026 21:18:25
Concord Biotech Q4 profit slides 37%, margins shrink; declares ₹7.55 dividend
Concord Biotech reported strong financial results for Q4 FY24, with net profit increasing 16.5% year-on-year to ₹130.4 crore and revenue from operations rising 19.3% to ₹301.6 crore. The company's EBITDA grew by 24.3% to ₹166.4 crore, and its EBITDA margin expanded to 55.2%. Additionally, the board recommended a final dividend of ₹7.5 per share for the fiscal year ended March 31, 2024, with a record date of July 26, 2024.
May 29 2026 19:07:12
Read More
Concord Biotech Management
| Name | Position |
|---|---|
| Sudhir Vaid | Chairman & Managing Director |
| Ankur Vaid | Joint Managing Director & CEO |
Concord Biotech Similar Stocks
Rainbow Children's Medicare Ltd.
1380.30
3.20 (0.23%)
Poly Medicure Ltd.
1349.70
19.40 (1.46%)
Vijaya Diagnostic Centre Ltd.
1308.50
47.10 (3.73%)
Alivus Life Sciences Ltd.
1055.50
-14.80 (1.38%)
Park Medi World Ltd.
288.54
2.07 (0.72%)
Sanofi Consumer Healthcare India Ltd.
4588.50
58.60 (1.29%)
Marksans Pharma Ltd.
246.19
-3.08 (1.24%)
Metropolis Healthcare Ltd.
555.35
19.20 (3.58%)
Viyash Scientific Ltd.
261.94
11.68 (4.67%)
Strides Pharma Science Ltd.
1111.80
-42.60 (3.69%)
Concord Biotech FAQs
The Buying Price of Concord Biotech share is 1051.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Biotech shares is 36.8. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Biotech shares is 6.08. Useful to assess the stock's value relative to its book value.
To assess Concord Biotech’s valuation compare Sector P/E, P/B which are 55.51 & 3.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Biotech is 10997.26 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Biotech share price is 2150.40 & 987.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Biotech belongs to the Healthcare sector.
